Generic Acomplia or Rimonabant is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Rimonabant has been found to stop food craving enough to help people lose weight, and could also help curb other unhealthy urges, such as smoking. This is a non-control weight loss solution that in one study, helped people who were overweight drop an average of 20 pounds, and was found to be very useful for patients who suffer from obesity. How does Rimonabant work?

Rimonabant is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. Rimonabant can also prevent the risk of cardiovascular disease. Patients with large waist circumference (102 cm in men and 88 cm in women) will mostly benefit from taking the drug.

What is Rimonabant used for?

Clinical trials have shown that heavy smokers, after being on a regular supplement of Rimonabant, have stopped smoking altogether. Smokers usually do not stop smoking for fear of weight-gain, which can be highly discouraging. However since Rimonabant works on the overeating and smoking factors simultaneously such problems wouldn’t arise. Does Rimonabant also aid smoking cessation?

Rimonabant acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle Rimonabant switches off the same brain circuits that make people hungry when they smoke cannabis CB1 receptor blockade with Rimonabant acts to decrease the over activity of the endocannabinoid system (EC system) 2, 3. The EC system is a recently characterized physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.